Published in J Pharm Sci on April 01, 2004
Herb-drug interactions: a literature review. Drugs (2005) 2.59
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med (2012) 2.13
St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol (2006) 1.60
Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res (2010) 1.26
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res (2008) 1.24
Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr (2009) 1.17
Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci (2006) 1.10
Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology (Oxford) (2010) 1.10
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) (2011) 1.05
The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent. J Ethnopharmacol (2011) 1.03
Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res (2009) 1.03
Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharm Res (2005) 1.01
Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun Mass Spectrom (2008) 0.95
Transdermal delivery of haloperidol by proniosomal formulations with non-ionic surfactants. Biol Pharm Bull (2009) 0.93
The role of the activin system in keloid pathogenesis. Am J Physiol Cell Physiol (2006) 0.93
Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Clin Pharmacokinet (2006) 0.93
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS One (2012) 0.90
Topotecan is a substrate for multidrug resistance associated protein 4. Curr Drug Metab (2006) 0.90
Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities. Small (2010) 0.89
A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities. Biomaterials (2010) 0.89
Inclusion of acitretin into cyclodextrins: phase solubility, photostability, and physicochemical characterization. J Pharm Sci (2003) 0.89
Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability. Mol Nutr Food Res (2013) 0.88
A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3,5,3',4'-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study. J Pharm Biomed Anal (2009) 0.88
Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. Int Immunopharmacol (2005) 0.88
Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci (2006) 0.88
Fluorescent nanogel of arsenic sulfide nanoclusters. Angew Chem Int Ed Engl (2009) 0.87
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients. PLoS One (2013) 0.86
Determination of Z-3,5,4'-trimethoxystilbene in rat plasma by a simple HPLC method: application in a pre-clinical pharmacokinetic study. J Pharm Biomed Anal (2010) 0.86
A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study. J Pharm Biomed Anal (2008) 0.86
Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm (2006) 0.86
Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry. J Proteome Res (2013) 0.85
Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma. Cancer Chemother Pharmacol (2008) 0.85
Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2011) 0.85
Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomedicine (2012) 0.85
Determination of trans-2,4,3',4',5'-pentamethoxystilbene in rat plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal (2011) 0.85
A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther (2006) 0.85
Impact of surface tension in pharmaceutical sciences. J Pharm Pharm Sci (2009) 0.85
Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy. Pharm Res (2010) 0.85
Infrared authentication of ginseng species: the use of the 2-6PC rule. J AOAC Int (2009) 0.84
Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability. J Pharm Sci (2011) 0.84
A simple method of microneedle array fabrication for transdermal drug delivery. Drug Dev Ind Pharm (2012) 0.84
Metabonomic profiling of bladder cancer. J Proteome Res (2014) 0.84
Integrin targeted drug and gene delivery. Expert Opin Drug Deliv (2010) 0.84
Insights into oxazaphosphorine resistance and possible approaches to its circumvention. Drug Resist Updat (2005) 0.83
St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats. Pharm Res (2005) 0.83
Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles. Biomaterials (2008) 0.83
Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.83
Monitoring drug-protein interaction. Clin Chim Acta (2005) 0.83
Quantification of oxyresveratrol analog trans-2,4,3',5'-tetramethoxystilbene in rat plasma by a rapid HPLC method: application in a pre-clinical pharmacokinetic study. Biomed Chromatogr (2010) 0.83
Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model. J Proteome Res (2012) 0.82
Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: application to a pharmacokinetic study. J Pharm Biomed Anal (2012) 0.82
Arsenic(II) sulfide quantum dots prepared by a wet process from its bulk. J Am Chem Soc (2008) 0.81
Quantification of trans-3,4,5,4'-Tetramethoxystilbene in rat plasma by HPLC: application to pharmacokinetic study. J Agric Food Chem (2011) 0.81
Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR. Eur J Pharm Sci (2011) 0.81
Overview on the analytical tools for quality control of natural product-based supplements: a case study of ginseng. Assay Drug Dev Technol (2005) 0.81
Single and multi-layered nanofibers for rapid and controlled drug delivery. Chem Pharm Bull (Tokyo) (2010) 0.80
The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells. Molecules (2013) 0.80
Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide. Curr Drug Metab (2006) 0.80
Applications of monolithic materials for sample preparation. J Pharm Biomed Anal (2013) 0.80
Smart polymeric nanofibers for topical delivery of levothyroxine. J Pharm Pharm Sci (2010) 0.80
Microfabricated particulate drug-delivery systems. Biotechnol J (2011) 0.80
Quantification of α- and β-amyrin in rat plasma by gas chromatography-mass spectrometry: application to preclinical pharmacokinetic study. J Mass Spectrom (2011) 0.80
Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum. Biol Pharm Bull (2003) 0.80
Novel agents that potentially inhibit irinotecan-induced diarrhea. Curr Med Chem (2005) 0.79
Evaluation of dried blood spots as sample matrix for gas chromatography/mass spectrometry based metabolomic profiling. Anal Chem (2011) 0.79
Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm (2010) 0.79
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat. J Pharm Biomed Anal (2005) 0.79
Curcumol induces apoptosis in SPC-A-1 human lung adenocarcinoma cells and displays anti-neoplastic effects in tumor bearing mice. Asian Pac J Cancer Prev (2015) 0.78
A novel dextran-oleate-cRGDfK conjugate for self-assembly of nanodrug. Nanomedicine (2011) 0.78
Authentication of traditional Chinese medicine using infrared spectroscopy: distinguishing between ginseng and its morphological fakes. J Biomed Sci (2006) 0.78
Identification of metabolites of meisoindigo in rat, pig and human liver microsomes by UFLC-MS/MS. Biochem Pharmacol (2009) 0.78
Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation. Int J Oncol (2011) 0.78
Determination of tributyrin and its metabolite butyrate in Wistar rat plasma samples by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2004) 0.78
Surface tension and wettability in transdermal delivery: a study on the in-vitro permeation of haloperidol with cyclodextrin across human epidermis. J Pharm Pharmacol (2010) 0.78
Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives. J Pharm Sci (2010) 0.78
CdSe/AsS core-shell quantum dots: preparation and two-photon fluorescence. J Am Chem Soc (2009) 0.77
Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry. Anal Bioanal Chem (2010) 0.77
Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension. Int J Pharm (2013) 0.77
Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells. Int J Oncol (2012) 0.77
Determination of naturally occurring resveratrol analog trans-4,4'-dihydroxystilbene in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study. Anal Bioanal Chem (2015) 0.77
A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS. Bioanalysis (2013) 0.77
Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target (2010) 0.77
A retrospective study on the usage of antiepileptic drugs in Asian children from 2000 to 2009 in the largest pediatric hospital in Singapore. Pharmacoepidemiol Drug Saf (2012) 0.77
Metabolically functional hepatocyte-like cells from human umbilical cord lining epithelial cells. Assay Drug Dev Technol (2012) 0.77
Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol. AAPS PharmSciTech (2010) 0.76
Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines. J Pharmacol Exp Ther (2005) 0.76
Development and characterization of skin permeation retardants and enhancers: a comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles. Biopharm Drug Dispos (2011) 0.76